Notice ID: 375fce98cf2e44b2a21e5c65cb98f5dfSpecial Notice
DARPA Surgical Competition (DSC) Second Industry Day
Active, responses due . Full description on SAM.gov.
Description
The Biological Technologies Office (BTO) of the Defense Advanced Research Projects Agency (DARPA) will host a Second Industry Day for potential competitors in the DARPA Surgical Competition (DSC). The Second Industry Day will be held on Wednesday November 4th, 2026, from 4:00 PM to 6:00 PM virtually. Advance registration is required. Note: all times listed in this announcement and on the registration website are Eastern Time.
Overview
Agency:
Department of WarDEFENSE ADVANCED RESEARCH PROJECTS AGENCY (DARPA)
Office:DEF ADVANCED RESEARCH PROJECTS AGCY
Posted:October 14, 2026
NAICS:541714: Research and Development in Biotechnology (except Nanobiotechnology)
Last Updated:Oct 21, 2026
First published:
Last updated on SAM.gov:
PSC:AC11: NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; BASIC RESEARCH
Set-Aside:Not specified
Type:Special Notice
Place of Performance:Not specified
Award Overview
Possible prior contracts
Sign in to see possible prior contracts for this requirement (matched by agency, NAICS and place of performance; not confirmed).
Contacts
Contracting Officer
Primary Contact
Jeremy Pamplin, BTO Program Manager
Documents
Files (1)
- Download
DARPA-SN-27-02.pdf
83 KBAdded in Special Notice version 1Posted
Lifecycle
- 1Version 1Special NoticeCurrent
DARPA Surgical Competition (DSC) Second Industry Day
Similar Opportunities
Title | Phase | Agency | NAICS | Set Aside | Posted | Deadline | Location |
|---|---|---|---|---|---|---|---|
The Ice Control for cold Environments (ICE) program BAA was solicited on August 15, 2022, for the purpose of seeking to develop solutions for extreme cold weather DoW operational challenges by discovering and optimizing biologically sourced or inspired molecules to enable tuned inhibition or nucleation of ice crystallization, propagation, and adhesion. The ICE BAA was solicited for Phase I and Phase II with a notional Phase III that was to be solicited at a later date. This justification provides the rationale for awarding a sole-source modification to the current Phase II contractor, to continue this work into Phase III under the authority of FAR 6.302-1, "Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements." | Sole Source / J&A | 541714 | No Set-Aside | 10/16/2026 | Open | Ann Arbor, MI | |
The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO) is soliciting proposals that leverage biological properties and processes to revolutionize our ability to protect the nation’s warfighters. Specifically excluded is research that primarily results in evolutionary improvements to the existing state of practice. | Solicitation | 541714 | No Set-Aside | 10/01/2025 | 09/30/2026 | - | |
The Ice Control for cold Environments (ICE) program BAA was solicited on August 15, 2022, for the purpose of seeking to develop solutions for extreme cold weather DoW operational challenges by discovering and optimizing biologically sourced or inspired molecules to enable tuned inhibition or nucleation of ice crystallization, propagation, and adhesion. The ICE BAA was solicited for Phase I and Phase II with a notional Phase III that was to be solicited at a later date. This justification provides the rationale for awarding a sole-source modification to the current Phase II contractor, to continue this work into Phase III under the authority of FAR 6.302-1, "Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements." | Sole Source / J&A | 541714 | No Set-Aside | 10/16/2026 | Open | Boston, MA | |
THIS NOTICE IS NOT A REQUEST FOR PROPOSALS OR A COMPETITIVE SOLICITATION. The Defense Advanced Research Projects Agency (DARPA) intends to enter into an Agreement with The University of Texas System consortium of universities in support of the Biological Technologies Office (BTO) LiveChain Program for an integrated research initiative focused on autonomous medical care, casualty evacuation, clinical decision support, and resilient medical supplies in austere and contested environments. | Special Notice | 541714 | No Set-Aside | 10/16/2026 | 11/15/2026 | - | |
The Defense Advanced Research Projects Agency (DARPA) is soliciting proposals to develop an in-silico capability for mapping all protein-protein interactions. Utility of this capability will be demonstrated in identifying novel diagnostic and therapeutic targets within the interaction space underlying including traumatic brain injury. | Solicitation | 541714 | No Set-Aside | 10/08/2026 | 11/05/2026 | - |
Additional Details
Solicitation Number
DARPA-SN-27-02
Archive Date
Nov 5, 2026
Office Address
ARLINGTON, VA, 222032114